Status:
RECRUITING
Deep Learning Using Chest X-Rays to Identify High Risk Patients for Lung Cancer Screening CT
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
Harvard Risk Management Foundation
Conditions:
Lung Cancer
Health Screening
Eligibility:
All Genders
50-77 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to evaluate whether an AI tool that alerts providers to patients at high 6-year risk of lung cancer based on their chest x-ray images will improve lung cancer screen...
Eligibility Criteria
Inclusion
- Major
- Scheduled outpatient appointment with participating provider.
- 50- to 77-year-old who currently or formerly smoked, to include persons potentially eligible for lung screening based on Medicare guidelines.
- Recent (within 2 years) PA chest radiograph.
Exclusion
- • History or signs/symptoms of lung cancer. Recent (within 2 years) chest CT. Clinical indication for chest CT beyond lung cancer screening.
Key Trial Info
Start Date :
May 20 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2027
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT06910956
Start Date
May 20 2025
End Date
July 1 2027
Last Update
June 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114